Updated Patent, Trade Mark, Copyright and other Acts

The post offers updated and amended versions of major Indian intellectual property statutes following the abolition of the IPAB. Downloadable resources and detailed amendment summaries are provided for reference.

Read more about Updated Patent, Trade Mark, Copyright and other Acts

Epic Games Sues VR Company, Mankind Pharma Secures Injunction and more

This bulletin examines recent trademark infringement cases in India and abroad, including Mankind Pharma’s injunction and Epic Games’ lawsuit. It also features brand licensing news and updates on geographical indication applications, offering a clear and factual legal analysis.

Read more about Epic Games Sues VR Company, Mankind Pharma Secures Injunction and more

In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

The article examines India’s policy on compulsory licensing for COVID-related medical technologies, echoing Prof. Arul Scaria’s critique of current government inaction. It highlights the legal and historical basis for compulsory licensing and argues for its strategic use to ensure public access to vaccines and medicines.

Read more about In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

Over 400 patent applications published on an early basis this week, over 1000 patents issued

Indian patent statistics for the week reveal increased early publications and patent grants, alongside a decrease in ordinary publications. The data provides a comprehensive overview of patent activity and design registrations across major Indian cities.

Read more about Over 400 patent applications published on an early basis this week, over 1000 patents issued

Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and more

Natco Pharma has withdrawn its compulsory license application for Baricitinib following an agreement with Eli Lilly. The Indian Patent Office has extended procedural deadlines, and other significant updates in IP law are discussed, including ongoing litigation and international proposals.

Read more about Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and more

Activity picks up slightly this week at the Patent Office

This post provides an objective analysis of Indian Patent Office statistics published for the week ending 21st May 2021. It details key figures on patent publications, grants, examinations, and design registrations, offering structured insights for intellectual property professionals.

Read more about Activity picks up slightly this week at the Patent Office

Free Master Class on IP for Start Ups, Entrepreneurs and SMEs

BananaIP and NASSCOM present a free master class on intellectual property for startups, entrepreneurs, and SMEs. Participants will gain essential insights on protecting and commercializing their innovations, with expert-led sessions focusing on patents and IP strategies.

Read more about Free Master Class on IP for Start Ups, Entrepreneurs and SMEs